Zefang Lu

Beijing Key Laboratory For Drug Delivery Nanocarriers
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Dietary fiber-based oral nanovaccine promotes gut-to-nose trafficking of regulatory cells and drives antigen-specific tolerance to relieve airway allergy.

Dietary fiber-based oral nanovaccine promotes gut-to-nose trafficking of regulatory cells and drives antigen-specific tolerance to relieve airway allergy.

Journal: iMeta

Published: June 16, 2026

Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models.

Reprogrammed apoptotic platelets drive rapid hemostasis through phosphatidylserine and prostaglandin E2 signaling in preclinical models.

Journal: Science translational medicine

Published: May 21, 2026

Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence.

Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: November 15, 2024

Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy.

Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy.

Journal: Cell reports. Medicine

Published: May 09, 2024

The dynamic role of platelets in cancer progression and their therapeutic implications.

The dynamic role of platelets in cancer progression and their therapeutic implications.

Journal: Nature reviews. Cancer

Published: October 13, 2023

Zinc nanoparticles from oral supplements accumulate in renal tumours and stimulate antitumour immune responses.

Zinc nanoparticles from oral supplements accumulate in renal tumours and stimulate antitumour immune responses.

Journal: Nature materials

Published: January 29, 2023

Monitoring circulating platelet activity to predict cancer-associated thrombosis.

Monitoring circulating platelet activity to predict cancer-associated thrombosis.

Journal: Cell reports methods

Published: January 13, 2023

Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Journal: Cancer research

Published: November 11, 2022

Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug.

Reducing Postoperative Recurrence of Early-Stage Hepatocellular Carcinoma by a Wound-Targeted Nanodrug.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 25, 2022

Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment.

Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment.

Journal: Nano letters

Published: March 02, 2021

Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction.

Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction.

Journal: Acta pharmaceutica Sinica. B

Published: May 22, 2020

Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.

Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: August 09, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026